297 related articles for article (PubMed ID: 37490064)
1. ETS1 Ameliorates Hyperoxia-Induced Bronchopulmonary Dysplasia in Mice by Activating Nrf2/HO-1 Mediated Ferroptosis.
Yang M; Chen Y; Huang X; Shen F; Meng Y
Lung; 2023 Aug; 201(4):425-441. PubMed ID: 37490064
[TBL] [Abstract][Full Text] [Related]
2. Lysine demethylase KDM3A alleviates hyperoxia-induced bronchopulmonary dysplasia in mice by promoting ETS1 expression.
Yang M; Chen Y; Huang X; Shen F; Meng Y
Exp Cell Res; 2024 Feb; 435(2):113945. PubMed ID: 38286256
[TBL] [Abstract][Full Text] [Related]
3. Melatonin Protects Against Hyperoxia-Induced Apoptosis in Alveolar Epithelial type II Cells by Activating the MT2/PI3K/AKT/ETS1 Signaling Pathway.
He F; Wang QF; Li L; Yu C; Liu CZ; Wei WC; Chen LP; Li HY
Lung; 2023 Apr; 201(2):225-234. PubMed ID: 36928143
[TBL] [Abstract][Full Text] [Related]
4. ETS1 Ameliorates Hyperoxia-Induced Alveolar Epithelial Cell Injury by Regulating the TGM2-Mediated Wnt/β-Catenin Pathway.
Yang M; Gao XR; Meng YN; Shen F; Chen YP
Lung; 2021 Dec; 199(6):681-690. PubMed ID: 34817668
[TBL] [Abstract][Full Text] [Related]
5. Irisin alleviates hyperoxia-induced bronchopulmonary dysplasia through activation of Nrf2/HO-1 pathway.
Zhao ZW; Lin XX; Guo YZ; He X; Zhang XT; Huang Y
Peptides; 2023 Dec; 170():171109. PubMed ID: 37804931
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of oxidative stress and Keap-1/Nrf2 signaling pathway in bronchopulmonary dysplasia.
Ma D; Gao W; Liu J; Kong D; Zhang Y; Qian M
Medicine (Baltimore); 2020 Jun; 99(26):e20433. PubMed ID: 32590729
[TBL] [Abstract][Full Text] [Related]
7. Cell Division Cycle 2 Protects Neonatal Rats Against Hyperoxia-Induced Bronchopulmonary Dysplasia.
Li Z; Chen Y; Li W; Yan F
Yonsei Med J; 2020 Aug; 61(8):679-688. PubMed ID: 32734731
[TBL] [Abstract][Full Text] [Related]
8. Regulating NLRP3 Inflammasome-Induced Pyroptosis via Nrf2: TBHQ Limits Hyperoxia-Induced Lung Injury in a Mouse Model of Bronchopulmonary Dysplasia.
Wang M; Zhang F; Ning X; Wu C; Zhou Y; Gou Z; Fan Y; Duan R; Li Z; Shao C; Lu L
Inflammation; 2023 Dec; 46(6):2386-2401. PubMed ID: 37556072
[TBL] [Abstract][Full Text] [Related]
9. BCL6 attenuates hyperoxia-induced lung injury by inhibiting NLRP3-mediated inflammation in fetal mouse.
Chen D; Zhao HM; Deng XH; Li SP; Zhou MH; Wu YX; Tong Y; Yu RQ; Pang QF
Exp Lung Res; 2024; 50(1):25-41. PubMed ID: 38419581
[TBL] [Abstract][Full Text] [Related]
10. The expression of miR-125b in Nrf2-silenced A549 cells exposed to hyperoxia and its relationship with apoptosis.
Zhang X; Chu X; Gong X; Zhou H; Cai C
J Cell Mol Med; 2020 Jan; 24(1):965-972. PubMed ID: 31713992
[TBL] [Abstract][Full Text] [Related]
11. [Berberine inhibits erastin-induced ferroptosis of mouse hippocampal neuronal cells possibly by activating the Nrf2-HO-1/GPX4 pathway].
Huang Q; Ji D; Tian X; Ma L; Sun X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jun; 42(6):937-943. PubMed ID: 35790446
[TBL] [Abstract][Full Text] [Related]
12. Effects of hyperoxia exposure on the expression of Nrf2 and heme oxygenase-1 in lung tissues of premature rats.
Chu X; Zhang X; Gong X; Zhou H; Cai C
Mol Cell Probes; 2020 Jun; 51():101529. PubMed ID: 32036037
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of PVT1 Enhances YTHDC1-Mediated m6A Modification of IL-33 in Hyperoxia-Induced Lung Injury During Bronchopulmonary Dysplasia.
Bao T; Liu X; Hu J; Ma M; Li J; Cao L; Yu B; Cheng H; Zhao S; Tian Z
Inflammation; 2024 Apr; 47(2):469-482. PubMed ID: 37917328
[TBL] [Abstract][Full Text] [Related]
14. Microbial-induced Redox Imbalance in the Neonatal Lung Is Ameliorated by Live Biotherapeutics.
Freeman AE; Willis KA; Qiao L; Abdelgawad AS; Halloran B; Rezonzew G; Nizami Z; Wenger N; Gaggar A; Ambalavanan N; Tipple TE; Lal CV
Am J Respir Cell Mol Biol; 2023 Mar; 68(3):267-278. PubMed ID: 36287630
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of microRNA-29a alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice via upregulation of GAB1.
Hu Y; Xie L; Yu J; Fu H; Zhou D; Liu H
Mol Med; 2019 Dec; 26(1):3. PubMed ID: 31892308
[TBL] [Abstract][Full Text] [Related]
16. SIRT3 improves alveolar epithelial cell damage caused by bronchopulmonary dysplasia through deacetylation of FOXO1.
Zang L; Chi J; Bi S; Tao Y; Wang R; Li L
Allergol Immunopathol (Madr); 2023; 51(2):191-204. PubMed ID: 36916106
[TBL] [Abstract][Full Text] [Related]
17. Preconditioning the immature lung with enhanced Nrf2 activity protects against oxidant-induced hypoalveolarization in mice.
Tamatam CM; Reddy NM; Potteti HR; Ankireddy A; Noone PM; Yamamoto M; Kensler TW; Reddy SP
Sci Rep; 2020 Nov; 10(1):19034. PubMed ID: 33149211
[TBL] [Abstract][Full Text] [Related]
18. Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia.
Ha AW; Sudhadevi T; Ebenezer DL; Fu P; Berdyshev EV; Ackerman SJ; Natarajan V; Harijith A
Am J Physiol Lung Cell Mol Physiol; 2020 Sep; 319(3):L497-L512. PubMed ID: 32697651
[TBL] [Abstract][Full Text] [Related]
19. Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms.
Chen X; Zhang X; Pan J
Med Sci Monit; 2019 Mar; 25():1886-1893. PubMed ID: 30862773
[TBL] [Abstract][Full Text] [Related]
20. Maresin-1 inhibits high glucose induced ferroptosis in ARPE-19 cells by activating the Nrf2/HO-1/GPX4 pathway.
Li Y; Liu J; Ma X; Bai X
BMC Ophthalmol; 2023 Sep; 23(1):368. PubMed ID: 37674121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
